2ND ANNUAL CANCER IMMUNOTHERAPY SUMMIT

In this summit, the most successful and promising new cancer treatment strategies will be explored. This summit is one of the most important opportunities, where you will explore the best practices in cancer immunotherapy. It is particularly important for the fields key opinion leaders, most exciting newcomers and others to come together to discuss and learn about the up-to-the-minute trends.

The summit ensures maximum knowledge transfer among professionals and decision makers to exchange and elaborate on the best practices and explore business partnership opportunities. This premier B2B summit is one of the few opportunities, where you will meet face to face with leading industry professionals and decision makers and discuss your business potential and opportunities. It will also enable the participants to learn about the most advanced techniques and tools through which they can assess their portfolios and development potential.

KEY TOPICS

EU and US Regulatory aspects

Management of side effects

What’s new in specific cancer types – News in specific cancer types

The true potential of the next generation immune checkpoint pathways

Resistance to therapy

Patient selection and predictive biomarkers

Advancements in T-cell engineering

Commercialization of Viable T-cell therapies

Revolutionary cancer treatment with personalised cancer vaccines

Combining immune checkpoint inhibitors with chemotherapy or radiotherapy and beyond

Technological developments

Preclinical and clinical progress in Cancer Immunotherapy

Advanced methods, technological developments and strategies in Cancer Immunotherapy

Imaging and nuclear medicine and design of immuno-oncology trials

Progressive genetic engineering techniques

WHY YOU SHOULD BE HERE?

Network with business development and licensing professionals as well as professionals in your sector

Implement the latest innovations

Learn about the latest technologies and most pressing topics specific to your business

Get an overview on innovative emerging technologies and promote business partnerships within the sector

Interact and connect with leading professionals

Discuss about new opportunities for your products and services with key decision makers

FEATURED SPEAKERS

Ivan Diaz-Padilla, MD, PhD

Senior Medical Director Oncology Global Development

Novartis

Louis Boon

Chief Scientific Officer

Bioceros

Dr. John Maher

Clinical Senior Lecturer/Honorary Consultant in Immunology

Kings College London

Dr. Marek Štastný, PhD.

Senior Scientific Advisor Oncology/Immuno-oncology

Bristol-Myers Squibb

Stefanos Theoharis

SVP Corporate Development and Partnering

Cell Medica

Larissa S. Carnevalli, PhD

Associate Principal Scientist Oncology Disease Models and Mechanisms Group

AstraZeneca

Madalin Sevestrian

Scientist

PAREXEL

Ronald Kurt Kuoch

Biomarker & Diagnostics Biopharma Global Early Development

Merck

Close

FEATURED COMPANIES

MEDIA PARTNERS

REQUEST FORM

Events | Terms and Conditions | Privacy Policy | Cookies Policy | Careers

Copyright 2018 © Sharonat Group s.r.o. All rights reserved.